Zohra Kalani
About Zohra Kalani
Zohra Kalani is a Scientist I at Tessera Therapeutics, specializing in the RNA Writer Platform. With a background in genetic research and a strong academic foundation from Brown University, she has accumulated extensive experience in various research roles since 2011.
Current Role at Tessera Therapeutics
Zohra Kalani serves as Scientist I in the RNA Writer Platform at Tessera Therapeutics. She has been in this position since 2022, contributing to the development of innovative RNA-based technologies. Her role involves applying her expertise in biotechnology to advance the company's research initiatives.
Previous Experience at Tessera Therapeutics
Prior to her current role, Zohra Kalani worked at Tessera Therapeutics as a Senior Research Associate from 2019 to 2021. In this capacity, she focused on research related to genetic engineering and RNA technologies, building a foundation for her current work in the RNA Writer Platform.
Research Experience at Broad Institute
Zohra Kalani was employed at the Broad Institute as a Research Associate II in the Genetic Perturbation Platform from 2015 to 2019. During her tenure, she engaged in research that contributed to advancements in genetic analysis and manipulation, enhancing her skills in the field.
Educational Background
Zohra Kalani earned her Master’s Degree in Biotechnology from Brown University, completing her studies from 2014 to 2015. She also holds a Bachelor of Science (B.S.) in Biology/Biological Sciences, which she obtained from 2010 to 2014 at the same institution. Her education provided her with a solid foundation in biological sciences and biotechnology.
Leadership Experience
During her time at Brown University, Zohra Kalani served as Chapter President of the Alpha Chi Omega Fraternity, Inc. from 2013 to 2014. This role involved leadership and organizational responsibilities, contributing to her development in team management and community engagement.